Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Xenon Pharmaceuticals Inc. per 2025 Jun 30 adalah 7.50 MM.
- Nilai operating income untuk Xenon Pharmaceuticals Inc. per 2025 Jun 30 adalah -318.12 MM.
- Nilai net income untuk Xenon Pharmaceuticals Inc. per 2025 Jun 30 adalah -278.23 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 7.50 | -318.12 | -278.23 |
2025-03-31 | 7.50 | -293.00 | -251.45 |
2024-12-31 | -279.30 | -234.33 | |
2024-09-30 | -255.52 | -213.39 | |
2024-06-30 | -237.52 | -199.06 | |
2024-03-31 | -224.04 | -188.60 | |
2023-12-31 | -214.05 | -182.39 | |
2023-09-30 | 0.00 | -203.69 | -175.04 |
2023-06-30 | 0.13 | -186.13 | -163.73 |
2023-03-31 | 0.67 | -160.82 | -147.43 |
2022-12-31 | 9.43 | -129.14 | -125.37 |
2022-09-30 | 13.17 | -110.65 | -113.54 |
2022-06-30 | 21.16 | -88.12 | -91.84 |
2022-03-31 | 22.84 | -80.30 | -82.79 |
2021-12-31 | 18.44 | -78.99 | -78.88 |
2021-09-30 | 19.85 | -67.08 | -65.64 |
2021-06-30 | 18.28 | -61.18 | -59.05 |
2021-03-31 | 29.45 | -39.33 | -37.12 |
2020-12-31 | 32.17 | -31.30 | -28.84 |
2020-09-30 | 30.34 | -29.98 | -27.89 |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | -3.01 | |
2024-09-30 | -2.82 | -2.82 |
2024-06-30 | -2.73 | -2.73 |
2024-03-31 | -2.70 | -2.70 |
2023-12-31 | -2.73 | |
2023-09-30 | -2.66 | -2.66 |
2023-06-30 | -2.49 | -2.49 |
2023-03-31 | -2.33 | -2.33 |
2022-12-31 | -2.06 | |
2022-09-30 | -1.81 | -1.81 |
2022-06-30 | -1.47 | -1.47 |
2022-03-31 | -1.56 | -1.56 |
2021-12-31 | -1.77 | |
2021-09-30 | -1.55 | -1.55 |
2021-06-30 | -1.40 | -1.40 |
2021-03-31 | -0.88 | -0.88 |
2020-12-31 | -0.80 | -0.80 |
2020-09-30 | -0.77 | -0.77 |
2020-06-30 | -0.77 | -0.77 |
2020-03-31 | -1.05 | -1.05 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Xenon Pharmaceuticals Inc. per 2025 Jun 30 adalah -229.94 MM.
- Nilai cash from investing activities untuk Xenon Pharmaceuticals Inc. per 2025 Jun 30 adalah 215.77 MM.
- Nilai kas dari aktivitas pendanaan untuk Xenon Pharmaceuticals Inc. per 2025 Jun 30 adalah 13.35 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -229.94 | 215.77 | 13.35 |
2025-03-31 | -196.85 | 242.70 | 13.28 |
2024-12-31 | -181.39 | 165.00 | 12.13 |
2024-09-30 | -163.89 | -171.81 | 324.01 |
2024-06-30 | -160.82 | -119.91 | 353.52 |
2024-03-31 | -162.89 | -201.20 | 353.52 |
2023-12-31 | -151.11 | -111.39 | 353.52 |
2023-09-30 | -148.44 | 114.07 | 29.51 |
2023-06-30 | -130.77 | -173.91 | 0.70 |
2023-03-31 | -114.41 | -200.49 | 270.60 |
2022-12-31 | -101.03 | -293.40 | 278.47 |
2022-09-30 | -86.41 | -497.10 | 602.42 |
2022-06-30 | -71.01 | -247.43 | 606.48 |
2022-03-31 | -67.22 | -240.55 | 336.70 |
2021-12-31 | -69.50 | -246.77 | 447.54 |
2021-09-30 | -61.91 | 11.86 | 123.64 |
2021-06-30 | -58.05 | -21.75 | 118.88 |
2021-03-31 | -55.77 | -19.00 | 102.05 |
2020-12-31 | -48.12 | -16.82 | 85.80 |
2020-09-30 | -15.22 | -120.34 | 113.18 |
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 | ||
2020-03-31 |
Efektivitas Manajemen
- roa untuk Xenon Pharmaceuticals Inc. pada 2025 Jun 30 adalah -0.28.
- roe untuk Xenon Pharmaceuticals Inc. pada 2025 Jun 30 adalah -0.30.
- roic untuk Xenon Pharmaceuticals Inc. pada 2025 Jun 30 adalah -0.35.
- croic untuk Xenon Pharmaceuticals Inc. pada 2025 Jun 30 adalah 0.08.
- ocroic untuk Xenon Pharmaceuticals Inc. pada 2025 Jun 30 adalah -0.28.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.28 | -0.30 | -0.35 | 0.08 | -0.28 |
2025-03-31 | -0.25 | -0.26 | -0.31 | -0.01 | -0.24 |
2024-12-31 | -0.22 | -0.25 | -0.26 | -0.01 | -0.19 |
2024-09-30 | -0.32 | -0.34 | -0.23 | 0.08 | -0.18 |
2024-06-30 | -0.26 | -0.27 | -0.21 | -0.01 | -0.17 |
2024-03-31 | -0.24 | -0.25 | -0.19 | 0.10 | -0.15 |
2023-12-31 | -0.23 | -0.23 | -0.27 | -0.01 | -0.22 |
2023-09-30 | -0.20 | -0.21 | -0.25 | -0.46 | -0.20 |
2023-06-30 | -0.18 | -0.21 | -0.25 | -0.46 | -0.20 |
2023-03-31 | -0.22 | -0.27 | -0.21 | -0.07 | -0.16 |
2022-12-31 | -0.43 | -0.46 | -0.15 | 0.02 | -0.11 |
2022-09-30 | -0.35 | -0.46 | -0.15 | 0.02 | -0.11 |
2022-06-30 | -0.30 | -0.36 | -0.12 | 0.36 | -0.09 |
2022-03-31 | -0.27 | -0.30 | -0.15 | 0.05 | -0.12 |
2021-12-31 | -0.35 | -0.46 | -0.14 | 0.23 | -0.25 |
2021-09-30 | -0.33 | -0.36 | -0.26 | 0.29 | -0.22 |
2021-06-30 | -0.28 | -0.31 | -0.23 | 0.15 | -0.22 |
2021-03-31 | -0.16 | -0.20 | -0.13 | 0.10 | -0.20 |
2020-12-31 | -0.20 | -0.31 | -0.17 | 0.12 | -0.28 |
2020-09-30 | -0.28 | -0.37 | -0.14 | -0.11 | -0.08 |
2020-06-30 | -0.26 | -0.34 | -0.13 | 0.03 | -0.05 |
2020-03-31 | -0.33 | -0.41 | -0.18 | 0.04 | -0.04 |
Gross Margins
- marjin kotor untuk Xenon Pharmaceuticals Inc. pada 2025 Jun 30 adalah -29.31.
- marjin bersih untuk Xenon Pharmaceuticals Inc. pada 2025 Jun 30 adalah -33.53.
- marjin operasi untuk Xenon Pharmaceuticals Inc. pada 2025 Jun 30 adalah -39.07.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | -29.31 | -33.53 | -39.07 |
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | -1,118.83 | -1,240.40 | -1,410.11 |
2023-06-30 | -187.51 | -1,240.40 | -1,410.11 |
2023-03-31 | -10.21 | -220.70 | -240.76 |
2022-12-31 | -6.05 | -8.62 | -8.40 |
2022-09-30 | -2.89 | -8.62 | -8.40 |
2022-06-30 | -2.44 | -4.34 | -4.16 |
2022-03-31 | -3.09 | -3.62 | -3.52 |
2021-12-31 | -2.45 | -4.28 | -4.28 |
2021-09-30 | -2.43 | -3.31 | -3.38 |
2021-06-30 | -2.43 | -3.23 | -3.35 |
2021-03-31 | -0.87 | -1.26 | -1.34 |
2020-12-31 | -0.57 | -0.90 | -0.97 |
2020-09-30 | -0.56 | -0.92 | -0.99 |
2020-06-30 | -0.61 | -1.02 | -1.07 |
2020-03-31 | -1.98 | -2.71 | -2.81 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1582313 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |